{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:15:43Z","timestamp":1790738143498,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jmig.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:13:17Z","timestamp":1594815197000},"page":"788-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-2736","authenticated-orcid":false,"given":"Olivia H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2020.07.006_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jmig.2013.07.008","article-title":"Incidence of unanticipated uterine pathology at the time of minimally invasive abdominal sacrocolpopexy","volume":"21","author":"Andy","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0002","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00192-012-1694-2","article-title":"Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction","volume":"23","author":"Ramm","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2020.07.006_bib0003","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00192-010-1101-9","article-title":"Uterus conserving prolapse surgery\u2013what is the chance of missing a malignancy?","volume":"21","author":"Renganathan","year":"2010","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2020.07.006_bib0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ajo.12033","article-title":"Risk of malignancy in women who underwent hysterectomy for uterine prolapse","volume":"53","author":"Wan","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0005","doi-asserted-by":"crossref","first-page":"507.e1","DOI":"10.1016\/j.ajog.2010.01.077","article-title":"Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse","volume":"202","author":"Frick","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0006","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/SPV.0000000000000283","article-title":"Incidence of occult uterine pathology in women undergoing hysterectomy with pelvic organ prolapse repair","volume":"22","author":"Ackenbom","year":"2016","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.jmig.2020.07.006_bib0007","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/SPV.0000000000000257","article-title":"Prevalence of occult malignancy within morcellated specimens removed during laparoscopic sacrocolpopexy","volume":"22","author":"Vallabh-Patel","year":"2016","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.jmig.2020.07.006_bib0008","unstructured":"United States Food & Drug Administration. Safety Communications. Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. Available at:https:\/\/wayback.archive-it.org\/7993\/20170406071822\/https:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm393576.htm. Accessed December 4, 2019."},{"key":"10.1016\/j.jmig.2020.07.006_bib0009","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/AOG.0000000000003181","article-title":"Hysterectomy practice patterns in the postmorcellation era","volume":"133","author":"Jorgensen","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00192-018-3790-4","article-title":"Route of hysterectomy during minimally invasive sacrocolpopexy does not affect postoperative outcomes","volume":"30","author":"Davidson","year":"2019","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2020.07.006_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SPV.0b013e318249bd54","article-title":"Effect of operative technique on mesh exposure in laparoscopic sacrocolpopexy","volume":"18","author":"Warner","year":"2012","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.jmig.2020.07.006_bib0012","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00192-020-04268-7","article-title":"Does concurrent posterior repair for an asymptomatic rectocele reduce the risk of surgical failure in patients undergoing sacrocolpopexy?","volume":"31","author":"Chang","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2020.07.006_bib0013","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00192-020-04291-8","article-title":"Long-term pelvic organ prolapse recurrence and mesh exposure following sacrocolpopexy","volume":"31","author":"Thomas","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jmig.2020.07.006_bib0014","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2014.07.054","article-title":"Perioperative adverse events after minimally invasive abdominal sacrocolpopexy","volume":"211","author":"Unger","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0015","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/SPV.0000000000000874","article-title":"Predictors for pelvic organ prolapse recurrence after sacrocolpopexy: a matched case-control study","volume":"27","author":"Chang","year":"2021","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.jmig.2020.07.006_bib0016","article-title":"Surgery for women with apical vaginal prolapse","volume":"10","author":"Maher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmig.2020.07.006_bib0017","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.AOG.0000462977.61229.de","article-title":"American College of Obstretricians and Gynecologists: Committee on Practice Bulletins\u2014Gynecology. Practice Bulletin No. 149: endometrial cancer","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0018","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/AOG.0000000000002521","article-title":"Occult gynecologic cancer in women undergoing hysterectomy or myomectomy for benign indications","volume":"131","author":"Desai","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0019","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","article-title":"Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis","volume":"19","author":"Crosbie","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jmig.2020.07.006_bib0020","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/AOG.0000000000002058","article-title":"Trends in mode of hysterectomy after the U.S. Food and Drug Administration power morcellation advisory","volume":"129","author":"Ottarsdottir","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0021","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/AOG.0000000000001111","article-title":"Association of the U.S. Food and Drug Administration morcellation warning with rates of minimally invasive hysterectomy and myomectomy","volume":"126","author":"Barron","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0022","doi-asserted-by":"crossref","first-page":"98.e1","DOI":"10.1016\/j.ajog.2015.08.047","article-title":"Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation","volume":"214","author":"Harris","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2020.07.006_bib0023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/SPV.0000000000000222","article-title":"Transvaginal versus transabdominal placement of synthetic mesh at time of sacrocolpopexy","volume":"22","author":"Nosti","year":"2016","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.jmig.2020.07.006_bib0024","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jmig.2019.08.010","article-title":"Perioperative outcomes of minimally invasive sacrocolpopexy based on route of concurrent hysterectomy: a secondary analysis of the National Surgical Quality Improvement Program Database","volume":"27","author":"Cardenas-Trowers","year":"2020","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020303368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465020303368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:39:23Z","timestamp":1761557963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465020303368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1553465020303368"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2020.07.006","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AAGL. All rights reserved.","name":"copyright","label":"Copyright"}]}}